Vironova AB

Vironova AB was founded in 2005 as a result of interdisciplinary research at the Karolinska Institute in Stockholm, Sweden and is today a fast growing company with around 130 employees. Vironova offers comprehensive hardware, software, and services for the analysis of nanoparticles. Vironova revolutionizes access to transmission electron microscopy–based image analysis in biopharmaceutical development. Our solution enables automated analyses for faster and better-informed decisions to secure robust bioprocessing and final product quality.